K Number
K203411
Device Name
syngo.CT Skull Unfolding
Date Cleared
2021-07-22

(245 days)

Product Code
Regulation Number
892.1750
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
syngo.CT Skull Unfolding provides curved MIP images of skull and brain surface for visual assessment by a radiologist.
Device Description
syngo.CT Skull Unfolding is image analysis software for CT volume data sets which has been continuously acquired with computed tomography (CT) imaging systems. syngo.CT Skull Unfolding provides advanced visualization of the skull and brain surface for easy manual identification, marking and reporting of pathologies such as skull fractures and hematomas. It receives images from a hosting application and returns DICOM images to a hosting application, which can display the results within its user interface. The device does not mark, highlight, or direct users' attention to a specific location in the original image.
More Information

No
The summary describes image analysis software using digital image processing and visualization tools, but there is no mention of AI, ML, or related concepts like deep learning or neural networks.

No
The device provides advanced visualization for diagnosis but does not directly treat or prevent a disease, nor does it restore, modify, or correct body function or structure.

Yes

Explanation: The "Intended Use / Indications for Use" section states that the device is for "visual assessment by a radiologist" to identify, mark, and report "pathologies such as skull fractures and hematomas," which is a diagnostic purpose.

Yes

The device is described as "image analysis software" that receives and returns DICOM images, indicating it is a software application processing existing medical images without requiring or including any specific hardware components for its primary function.

Based on the provided information, this device is NOT an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information about a person's health.
  • Device Function: syngo.CT Skull Unfolding is image analysis software that processes CT volume data sets acquired from a CT scanner. It works with images of the skull and brain surface, not biological specimens.
  • Intended Use: The intended use is for visual assessment by a radiologist of curved MIP images derived from CT scans. This is a diagnostic process based on imaging, not laboratory testing of biological samples.

The description clearly indicates that the device operates on medical images obtained through a non-invasive imaging modality (CT) and provides visualization tools for interpretation by a qualified clinician. This aligns with the definition of a medical imaging software device, not an IVD.

N/A

Intended Use / Indications for Use

syngo.CT Skull Unfolding provides curved MIP images of skull and brain surface for visual assessment by a radiologist.

Product codes

JAK

Device Description

syngo.CT Skull Unfolding is image analysis software for CT volume data sets which has been continuously acquired with computed tomography (CT) imaging systems. syngo.CT Skull Unfolding provides advanced visualization of the skull and brain surface for easy manual identification, marking and reporting of pathologies such as skull fractures and hematomas. It receives images from a hosting application and returns DICOM images to a hosting application, which can display the results within its user interface. The device does not mark, highlight, or direct users' attention to a specific location in the original image.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

CT

Anatomical Site

skull and brain surface

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Qualified clinicians

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

This submission contains performance tests (Non-clinical test reports) to demonstrate continued conformance with special controls for medical devices containing software. Non-clinical tests (integration and functional) were conducted for syngo.CT Skull Unfolding during product development. These tests have been performed to test the ability of the included features of the subject device. The results of these tests demonstrate that the subject device performs as intended. The result of all conducted testing was found acceptable to support the claim of substantial equivalence.
The risk analysis was completed, and risk control implemented to mitigate identified hazards. The testing results support that all the software specifications have met the acceptance criteria. Testing for verification and validation of the device was found acceptable to support the claims of substantial equivalence.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K123584

Reference Device(s)

K191040

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.1750 Computed tomography x-ray system.

(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA acronym with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name written out to the right of the square. The full name of the agency is "U.S. Food & Drug Administration".

Siemens Medical Solutions USA, Inc. % Tabitha Estes Regulatory Affairs Specialist 810 Innovation Drive KNOXVILLE TN 37932

Re: K203411

Trade/Device Name: syngo.CT Skull Unfolding Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: Class II Product Code: JAK Dated: June 18, 2021 Received: June 21, 2021

Dear Tabitha Estes:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmp/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see

July 22, 2021

1

https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

For

Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K203411

Device Name syngo.CT Skull Unfolding

Indications for Use (Describe)

syngo.CT Skull Unfolding provides curved MIP images of skull and brain surface for visual assessment by a radiologist.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(k) Summary

FOR

SYNGO.CT SKULL UNFOLDING

K203411

Identification of the Submitter l.

Importer/Distributor

Siemens Medical Solutions USA, Inc. 40 Liberty Boulevard Malvern, PA 19355

Establishment Registration Number

2240869

Manufacturing Site

Siemens Healthcare GmbH Siemensstr 1 D-91301 Forchheim, Germany

Establishment Registration Number

3004977335

Submitter Contact Person:

Tabitha Estes Regulatory Affairs Specialist Siemens Medical Solutions, Inc. USA 810 Innovation Drive Knoxville, TN 37932 Phone: (865) 804-4553 Email: tabitha.estes@siemens-healthineers.com

Alternate Contact:

Alaine Medio

Device Name and Classification II.

Product Name:syngo.CT Skull Unfolding
Propriety Trade Name:syngo.CT Skull Unfolding
Classification Name:System, X-Ray, Tomography, Computed
Classification Panel:Radiology
CFR Section:21 CFR §892.1750
Device Class:Class II
Product Code:JAK

4

lll. Predicate Device

Predicate Device:

Trade Name:syngo.CT Bone Reading
510(k) Number:K123584
Clearance Date:03/12/2013
Classification Name:System, X-Ray, Tomography, Computed
Classification Panel:Radiology
CFR Section:21 CFR §892.1750
Device Class:Class II
Product Code:JAK

Reference Device:

Trade Name:syngo.via VB40
510(k) Number:K191040
Clearance Date:05/16/2019
Classification Name:System, X-Ray, Tomography, Computed
Classification Panel:Radiology
CFR Section:21 CFR §892.1750
Device Class:Class II
Product Code:JAK

IV. Device Description

This section describes the technical features and workflow for subject device syngo.CT Skull Unfolding. syngo.CT Skull Unfolding is image analysis software for CT volume data sets which has been continuously acquired with computed tomography (CT) imaging systems. syngo.CT Skull Unfolding provides advanced visualization of the skull and brain surface for easy manual identification, marking and reporting of pathologies such as skull fractures and hematomas. It receives images from a hosting application and returns DICOM images to a hosting application, which can display the results within its user interface. The device does not mark, highlight, or direct users' attention to a specific location in the original image.

V. Indications for Use

syngo.CT Skull Unfolding provides curved MIP images of skull and brain surface for visual assessment by a radiologist.

Comparison of Technological Characteristics with the Predicate Device VI.

The differences and similarities between the above referenced predicate device are listed at a highlevel in the following table:

5

FeaturesSubject DevicePredicate DeviceReference DeviceSummary
Siemens
syngo.CT Skull UnfoldingSiemens
syngo.CT Bone ReadingSiemens
syngo.via VB40
Advanced
VisualizationUnfolded view of the
skullUnfolded view of the
ribsAdvanced visualization of
Curved spine rangesComparable
Both subject and
predicate device provide
unfolded views of the
respective anatomy as
advanced visualization
Visualization
TechniquesCurved maximum
intensity projection
(MIP)Curved multiplanar
reconstruction (MPR)
and other filter
techniques (multiplanar
reconstruction (MPR)
thin/thick, maximum
intensity projection
(MIP) thin/thick, inverted
MIP thin/thick, volume
rendering technique
(VRT))Curved multiplanar
reconstruction (MPR)
and other filter
techniques (multiplanar
reconstruction (MPR)
thin/thick, maximum
intensity projection
(MIP) thin/thick, inverted
MIP thin/thick, volume
rendering technique
(VRT))Similar
Both, the subject device,
and the reference device
provide curved
visualizations. The subject
device represents a
subset of functionalities.
Localization of
AnatomyHead localization via
anatomical range "Head
Orbitomeatal" based on
landmark detectionSpine Localization via
spine range based on
landmark detectionAnatomical auto views
and anatomical ranges
(by selecting anatomical
presets, e.g. "Head
Orbitomeatal") based on
landmark detection.Similar
The subject device uses
the same anatomical
range "Head
Orbitomeatal" of the
reference device.
For both subject and
predicate device, the
fundamental technology
is the same but different
landmarks are used due
to different anatomy.
Bone
SegmentationThresholding based skull
segmentationRib segmentation by
model fittingHU-based threshold
segmentation in the
Anatomy VisualizerSimilar
Both subject and
predicate device
comprise a bone
segmentation, but use
different well-established
techniques
Output Image
ТуреCurved MIP RangesCurved CPR RangesVarious types, including
curved ranges and MIP
rangesComparable
For both subject and
predicate device, the
output image types are
commonly used image
representations for 3D CT
data
Additional
FunctionalityPicking on 2D view with
automatic
synchronization of 3D
viewsPicking on 2D view with
automatic
synchronization of 3D
viewsVarious functionality for
viewing, manipulation,
communication, and
storage of medical
imagesSame
Subject and predicate
device both provide
picking and
synchronization
functionality
FeaturesSubject DevicePredicate DeviceReference DeviceSummary
Siemens
syngo.CT Skull UnfoldingSiemens
syngo.CT Bone ReadingSiemens
syngo.via VB40
Measurement
ToolsNon-measurement tools
(e.g. marker, arrow)Geometric tools, HU
measurement tools, non-
measurement tools (e.g.
marker, arrow)Geometric tools, HU
measurement tools, non-
measurement tools (e.g.
marker, arrow)Similar
The subject device
provides a subset of tools
of the predicate device
and the reference device.
Editing and
Creation ToolsN/ATools to create and edit
anatomical centerline
paths and anatomical
labelsTools to create and edit
anatomical centerline
paths and anatomical
labelsDifferent
The subject device
provides no editing and
creation tools as no labels
and centerlines are
created.
Intended UserQualified cliniciansQualified cliniciansQualified cliniciansSame
Radiological
images formatDICOMDICOMDICOMSame
Independent of
standard of care
workflowYes; Advanced
visualization in addition
to standard imagesYes; Advanced
visualization in addition
to standard imagesN/ASame
ModalityNon-contrast CTNon-contrast CTMulti-modal, e.g. CT, MRSame
Subject and predicate
device work on non-
contrast CT images
Archiving/StoringCD-R, film, DVD, USB,
NetworkCD-R, film, DVD, USB,
NetworkCD-R, film, DVD, USB,
NetworkSame
CommunicationDICOM compatibleDICOM compatibleDICOM compatibleSame

6

IFU Comparison

The subsection provides a comparison discussion of the IFU statement for the subject device and predicate device.

Subject DevicePredicate Device
Siemens
syngo.CT Skull UnfoldingSiemens
syngo.CT Bone Reading
syngo.CT Skull Unfolding provides curved MIP images of
skull and brain surface for visual assessment by a
radiologist.The syngo.CT Bone Reading is image analysis software for
CT volume data sets which has been continuously acquired
with computed tomography (CT) imaging systems. The
software combines following digital image processing and
visualization tools:

multiplanar reconstruction (MPR) thin/thick, maximum
intensity projection (MIP) thin/thick, inverted MIP
thin/thick, volume rendering technique (VRT) geometric measurement tools (distance line, polyline,
marker, arrow, angle) HU measurement tools (Pixel lens, ROI circle, ROI
polygonal, ROI freehand, VOI sphere) curved MPR visualization (unfolded ribs and spine
views), cross-section MPRs |

7

| | tools for creation and editing of anatomical centerline paths tools for creation and editing of anatomical labels The specific visualizations of spine and rib structures allow for easy manual identification and marking of pathologies such as bone lesions or fractures.
Reporting and documentation of results is facilitated by using of appropriate reporting tool, statistics and creation of ranges and snapshots. |

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The IFU statement of the subject device is not identical as compared to the predicate device, but similar. The predicate device used for this submission is syngo.CT Bone Reading (K123584, clearance date 03/12/2013).

Both devices provide technology to unfold bones. The main difference is that the predicate device is designed for unfolding spine and rib structures and the subject device for the skull.

The subject device represents a visualization method. Despite addressing a different anatomical region, the subject device's IFU can be considered as a subset of the predicate device's IFU. The differences are not critical to the intended use:

  • Visualization techniques: Besides showing the unfolded ribs/spine in curved MPR format, the predicate device provides different filtering techniques for visualization of the input CT dataset ("multiplanar reconstruction (MPR) thin/thick, maximum intensity projection (MIP) thin/thick, inverted MIP thin/thick, volume rendering technique (VRT)"). These possibilities are not unique to the predicate device, but are offered by many standard diagnostic viewing systems (e.g. syngo.via (K191040)). In comparison, the subject device only provides a single visualization technique for the skull and brain surface (curved MIP). However, the user can use a standard diagnostic viewing system to also apply different visualization techniques to the input CT datasets.
  • . Measurement tools: The predicate device IFU lists geometric and HU measurement tools. Due to the distortions in the subject device, linear measurement tools (e.g. distance line, angle) cannot be used. The subject device enables the use of non-measurement tools (e.g. marker, arrow), but they are not listed within the IFU.
  • . Tools for creation and editing: The predicate device offers tools to create and edit anatomical centerline paths and anatomical labels. This possibility is specific for the anatomical regions of predicate device (i.e. for spine and ribs) and is not required, and therefore not offered, for the subject device (i.e. skull and brain surface).

Conclusion of the Comparison

To summarize, the IFU differences in the technological characteristics do not affect the subject device's intended use. For the subject device, syngo.CT Skull Unfolding, Siemens used the same testing methods with same workflows as used to clear the predicate device. The development and testing process remain unchanged. Siemens considers syngo.CT Skull Unfolding to be as safe, as effective and with performance substantially equivalent to the commercially available predicate device.

In addition, completion of risk/hazard analysis, non-clinical data-based software validation supports that the used technology in the subject device does not raise different questions of safety and effectiveness.

8

VII. Performance Data

The following performance data were provided in support of the substantial equivalence determination.

Non-Clinical Testing

This submission contains performance tests (Non-clinical test reports) to demonstrate continued conformance with special controls for medical devices containing software. Non-clinical tests (integration and functional) were conducted for syngo.CT Skull Unfolding during product development. These tests have been performed to test the ability of the included features of the subject device. The results of these tests demonstrate that the subject device performs as intended. The result of all conducted testing was found acceptable to support the claim of substantial equivalence.

Risk Analysis

The risk analysis was completed, and risk control implemented to mitigate identified hazards. The testing results support that all the software specifications have met the acceptance criteria. Testing for verification and validation of the device was found acceptable to support the claims of substantial equivalence.

Standards and utilized FDA Guidances

Siemens hereby certifies that syngo.CT Skull Unfolding will meet the following voluntary standards covering electrical and mechanical safety listed below, prior to introduction into interstate commerce:

| Recognition
Number | Product
Area | Title of Standard | Date of
Recognition | Standards
Development
Organization |
|-----------------------|--------------------------|------------------------------------------------------------------------------------------------------------|------------------------|------------------------------------------|
| 12-300 | Radiology | Digital Imaging and Communications in
Medicine (DICOM) Set; PS 3.1 – 3.20 | 06/27/2016 | NEMA |
| 13-79 | Software | Medical Device Software - Software Life
Cycle Processes; 62304:2006 (1st Edition) | 01/14/2019 | AAMI, ANSI, IEC |
| 5-40 | Software/
Informatics | Medical devices – Application of risk
management to medical devices; 14971
Second Edition 2007-03-01 | 06/27/2016 | ISO |
| 5-114 | General I
(QS/RM) | Medical devices - Part 1: Application of
usability engineering to medical devices
IEC 62366-1:2015 | 12/23/2016 | IEC |

For the development of the product as well as the 510(k) submission, the following FDA guidances has been considered:

  • Content of Premarket Submissions for Management of Cybersecurity in Medical Devices
  • . Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices
  • The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]
  • Deciding When to Submit a 510(k) for a Software Change to an Existing Device
  • Format for Traditional and Abbreviated 510(k)s

9

VIII. Conclusion

syngo.CT Skull Unfolding has the same intended use and similar indication for use as the predicate device. The result of all testing conducted was found acceptable to support the claim of substantial equivalence. The comparison of technological characteristics, non-clinical performance data, and software validation demonstrates that the subject device is as safe and effective when compared to the predicate device that is currently marketed for the same intended use. For the subject device, syngo.CT Skull Unfolding, Siemens used the same testing with the same workflows as used to clear the predicate device. Siemens considers syngo.CT Skull Unfolding to be as safe, as effective and with performance substantially equivalent to the commercially available predicate device.